ABSTRACT
INTRODUCTION
Congenital diaphragmatic hernia (CDH) is a lifethreatening condition mainly because of associated neonatal respiratory failure due to lung hypoplasia and persistent pulmonary hypertension (PPH) [1] [2] [3] [4] . PPH is caused by abnormal transition of the fetal to neonatal circulation 5 . The persistently elevated pulmonary vascular resistance causes right-to-left shunting of deoxygenated blood to the systemic circulation, resulting in arterial hypoxia and, ultimately, right ventricular failure with systemic hypotension and obstructive shock [6] [7] [8] [9] . As opposed to other causes of neonatal respiratory failure, infants with CDH often present with refractory PPH resistant to inhaled nitric oxide (iNO) 10, 11 . When maximal medical therapy has failed, one may resort to extracorporeal membrane oxygenation (ECMO) 12 , although there is a lack of evidence for its efficacy 13 . The main concerns with ECMO are the occurrence of hemorrhagic and ischemic cerebral lesions resulting in later neurological and neurodevelopmental dysfunction 14, 15 . Several studies have also reported an effect of ECMO on non-neurological short-term problems with feeding, growth and lung function 16, 17 . Given the severity and potential morbidity of PPH, as well as the potential side-effects of ECMO, different research groups have searched for antenatal predictors to personalize the prognosis for women carrying a fetus with severe CDH. Ultrasound (US) and magnetic resonance imaging (MRI) have both been used to assess the degree of lung hypoplasia and lung vascularization. The best validated is US measurement of lung size, which allows the expression of parenchymal lung development as a function of what is expected 18, 19 . Conversely, much less attention has been given to assessment of lung vascularization and the prediction of postnatal cardiovascular function 20, 21 . The aim of the present study was to identify predictors of PPH and ECMO by a systematic review of the literature.
METHODS
This study was carried out according to the guidelines for systematic reviews, Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), and of the Synthesizing Evidence from Diagnostic Accuracy Tests (SEDATE) 22, 23 . The protocol of the review was registered in the PROSPERO registry (CRD 42015027272).
Search strategy
An electronic literature search for antenatal diagnostic studies predicting the occurrence of PPH or the need for ECMO was performed in MEDLINE via PubMed, EMBASE, Web of Science and The Cochrane Central Register of Controlled Trials (CENTRAL) to identify studies published from inception to June 2015. The electronic search strategy included both Medical Subject Headings (MeSH) and keywords (free text words), and is detailed in Appendix S1. Endnote X7 (Thomson Reuters, Carlsbad, CA, USA) was used to eliminate duplicate reports. Reference lists and topic-related reviews were checked manually to identify further relevant papers.
Selection of studies
The studies were selected in two phases. First, titles and abstracts of the listed articles were screened by one reviewer (F.M.R.) using a high-sensitivity, low-specificity assessment of relevance. Full-text copies of the selected articles were assessed independently for their eligibility by two investigators (F.M.R. and M.P.E.) according to the inclusion and exclusion criteria described below. Disagreements between reviewers were resolved by discussion or by a third reviewer (J.D.). In the case of overlapping studies, only the largest and most complete dataset was included.
Inclusion and exclusion criteria
Both observational and interventional studies were retrieved for further analysis. No language restriction was used. Studies and/or subgroups were included only if they reported adequately on study population, definition of prenatal tests and postnatal outcome (PPH and/or ECMO). In the case of missing information, the corresponding authors of the study were contacted and asked to provide additional data using a standardized questionnaire. A 'PIRT' (Patient-Index test-Reference test-Target condition), analogous to the 'PICO' (Patient-Intervention-Comparison-Outcome) for systematic reviews of interventional studies, was used to define the specific questions to be assessed 24, 25 . We included only studies on fetuses with isolated CDH (i.e. without associated anatomical malformations or genetic anomalies), regardless of the side of the defect and the degree of lung hypoplasia. Cases that underwent fetal therapy and cases managed expectantly during pregnancy were included. Studies on all relevant tests were eligible for inclusion if an accurate description of the technique was provided.
We excluded studies that were published as case reports, reviews or articles with no full text available and studies reporting only outcomes beyond 1 month of age. Studies reporting on ex-utero intrapartum treatment with ECMO were excluded. Patients who underwent termination of pregnancy, fetuses with associated major malformations or genetic problems and cases lacking information on postnatal outcome were also excluded.
Primary outcomes
Primary outcomes assessed were the need for ECMO, applied according to consensus criteria 26, 27 , and PPH within 28 days of age. PPH was defined as the presence of tricuspid regurgitation, septal bowing and continuous or dominant right-to-left shunting through a patent ductus arteriosus on cardiac ultrasound or by a preductal-postductal saturation difference of ≥ 10% 28, 29 . Since PPH is an indication for initiating iNO or other vasodilators, studies reporting this type of neonatal outcome were also included.
Quality assessment of studies
Two reviewers (F.M.R. and M.P.E.) assessed independently the methodological quality of each included study with the QUality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) 30 . Four domains, covering participant selection, index test, reference standard and flow of patients through the study, were rated for risk of bias (low, high or unclear) and applicability concerns. Three additional items -definition of the positivity threshold of the index test, any treatment given between prenatal assessment and postnatal evaluation that might have affected the outcome and observer variation -were considered of interest in this review and were also scored 31 . Discrepancies between the reviewers were resolved through consensus or by a third reviewer (J.D.). Agreement between the two reviewers was analyzed with Cohen's kappa test.
Data extraction and analysis
A predesigned form was used for data extraction, which was carried out independently by two authors (F.M.R. and M.P.E.). The selected studies were coded for participant characteristics, test characteristics and methodological aspects. Participant characteristics included the hospital in which the patient was evaluated, side of defect, associated anomalies, degree of lung hypoplasia and pre-and postnatal management. Subgroup analysis for PPH or use of vasodilators and need for ECMO was performed to test for differences between the two outcomes and guarantee homogeneity among the groups.
For all variables reported on by at least three studies, we performed a meta-analysis of the results. Variables were tested for statistical heterogeneity by applying the I 2 test. Results were expressed as relative risk (RR) for categorical variables and standardized mean difference (SMD) for continuous variables. A random-effects model was used. For meta-analyses including at least 10 studies, publication bias was analyzed by visual inspection of the funnel plot. MedCalc statistical software version 15.4 (MedCalc Software bvba, Ostend, Belgium) was used to carry out statistical analysis.
RESULTS

Search results
The search strategy yielded 3533 citations. Of these, 3442 were excluded by review of the title and abstract, as they failed to meet the inclusion criteria. The full article was reviewed for 91 studies, of which 38 were included in the systematic review. The principal reasons for exclusion after examination of the full article were overlapping datasets (n = 17), not matching the review question (n = 16) and inclusion of a different study population (i.e. postnatal series, n = 5), in addition to a number of other reasons (n = 15). Of the selected papers, 15 reported on the occurrence of PPH 20, 21, 26, [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] , 19 on the need for ECMO [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] and four reported on both outcomes [63] [64] [65] [66] ( Figure 1 ). The corresponding authors of seven studies provided relevant unpublished data 32, 35, 37, 55, 63, 64, 66 .
Characteristics and quality of included studies
Details on the design, setting, population, index test and definition of the primary outcome are provided in Table S1 . Thirty-five studies (92%) were performed at a single center and 23 (61%) 20 . Quality assessment of the included studies is summarized in Figures 2 and S1. The agreement between the two reviewers in determining the risk of bias was good, the kappa coefficient ranging from 0.797 to 0.901 for the different domains. Overall, the methodological quality was moderate. The domains index test and reference standard were those most frequently associated with an uncertain or high risk of basis. Gestational age at testing was not specified or was broad in 21 studies (55%) 21, [34] [35] [36] [37] [38] [39] 44, 45, [47] [48] [49] [50] [51] [52] 54, [56] [57] [58] [59] 66 . In five studies (13%), the positivity threshold of the index test was not prespecified 50, 53, 54, 63, 66 . Fifteen studies (39%) did not mention blinding to the reference standard in the interpretation of the index test 21, [35] [36] [37] [40] [41] [42] [43] 47, 48, 58, 60, 62, 65, 66 . The proportion of studies with an uncertain or high risk of bias in the reference standard domain was higher for studies reporting on PPH than for those reporting on the need for ECMO (89% vs 48%, respectively). The main cause of bias for PPH studies was the absence of specified timing for the reference test for the diagnosis of PPH. This was provided in the article for a single study 63 and on request from the author of another study 64 . Table 1 summarizes the antenatal tests used for the prediction of PPH. These were mainly related to measurement of lung size, using either US or MRI. The most commonly proposed tests were lung-to-head ratio (LHR), observed to expected LHR (o/e-LHR) and o/e total lung volume (o/e-TLV), reported in seven 26, 35, 37, 41, 43, 63, 64 , five 32, 33, 37, 41, 43 and four 21, 26, 41, 43 Potential citations identified by searching PubMed, EMBASE, Web of Science and CENTRAL and by manual search (from inception of each database to June 2015) (n = 3533)
Proposed predictors of PPH
Excluded by title and abstract (n = 3442)
Eligible for full-text evaluation (n = 91)
Included studies (n = 38)
Excluded studies (n = 53) Overlapping datasets (n = 17) Did not match review question (no PPH or ECMO) (n = 16) Different study population Neonatal series (n = 5) studies, respectively. Tests for direct assessment of the pulmonary vasculature, either anatomical or functional, have also been proposed 26, [32] [33] [34] [38] [39] [40] . However, these variables were evaluated in a single series or in different series by the same principal investigator (n = 2). Still, a shorter o/e contralateral pulmonary artery diameter and a lower contralateral vascularization index consistently predicted an increased risk of PPH [38] [39] [40] . Conversely, the side of the hernia consistently did not predict the occurrence of PPH in both studies in which it was evaluated 40, 43 . The predictive value of liver herniation was assessed in five studies 37, 43, 63, 64, 66 , without consistency among the results from different series. Figure 3 shows forest plots for the association between predictors evaluated in at least three studies and the occurrence of PPH. Summary data from individual studies included in the meta-analysis are provided in Table S2 . The occurrence of PPH was not significantly associated with a LHR < 1 (RR, 1.44 (95% CI, 0.42-4.95)) or a lower mean o/e-LHR (SMD, -0.60 (95% CI, -1.18 to 0.07)). However, we observed high heterogeneity between studies for both tests. The results of the four studies reporting LHR that were not included in the meta-analysis, because they reported either odds ratios 43 or mean LHR values 28, 37, 41 , were not homogeneous, with two studies demonstrating an association between low LHR and PPH and two with opposite results. Similarly, two studies reporting on the predictive value of o/e-LHR were not included because the results were presented as median and interquartile range 33 or odds ratios 43 . However, both these studies showed an association between a lower o/e LHR and PPH.
Results from studies reporting on o/e-TLV could not be pooled because of high heterogeneity in the methodology for measuring o/e-TLV (two studies by US 21, 41 and two by MRI 26, 43 ) , the study population and the reporting of statistical results. The results were not consistent among studies, with three studies supporting a correlation of a lower o/e-TLV with the occurrence of PPH 21, 41, 43 and one failing to show a significant association 26 .
Liver herniation did not significantly predict the occurrence of PPH (RR, 1.30 (95% CI, 0.79-2.13)). There was high heterogeneity among studies (I 2 = 96.51%, P = 0.0001).
In an attempt to remove the confounding effect of intrauterine therapy on the occurrence of PPH, we subsequently performed a sensitivity analysis on studies that included only patients managed expectantly in utero. This led to only two studies being available for meta-analysis on LHR < 1 35, 63 and mean o/e-LHR 37, 41 and three studies evaluating the predictive value of liver herniation 37, 63, 66 . 
Proposed predictors of need for ECMO
Antenatal predictive tests of the need for ECMO are shown in Table 2 . As for PPH, the most commonly proposed tests assessed lung size. LHR was evaluated in 11 studies 45, 50, 51, [54] [55] [56] [57] [58] 60, 63, 64 , o/e-LHR in four 51, 55, 56, 58 and o/e-TLV in five 46, 55, 57, 58, 61 . Assessment of organs other than the lungs was also reported. Of these, the most common parameter was the presence of liver herniation, which was evaluated in 11 studies 44, 45, 47, [50] [51] [52] 56, 57, 61, 64, 66 using either US (10 studies) or MRI (one study). One study looked at the amount of liver in the chest as a predictor 47 . There was no consistency in any outcome of these studies in terms of predicting the need for ECMO. As was found for PPH, the side of the hernia was not associated with the need for ECMO in the three studies in which it was evaluated 47, 56, 61 . Meta-analysis was performed on studies evaluating the association of ECMO with LHR < 1 (n = 6), lower mean LHR (n = 4), mean o/e-LHR (n = 3) and mean o/e-TLV (n = 4) (Figure 4) , these being the only predictors reported in at least three studies, aside from liver herniation. A lower lung size significantly predicted the need for ECMO in all cases, with a pooled RR of 1.65 (95% CI, 1.27-2.14) for LHR < 1 and pooled SMDs of -0.73 (95% CI, -1.07 to -0.42), -0.70 (95% CI, -0.98 to -0.42) and -1.00 (95% CI, -1.52 to -0.48) for mean LHR, mean o/e-LHR and mean o/e-TLV, respectively. Summary data from individual studies included in the meta-analysis are provided in Table S3 . Low heterogeneity was observed among different studies. One paper reporting the predictive value of LHR and o/e-LHR was not included in the meta-analysis because the results were expressed as odds ratios 56 . In that study, the two tests did not predict the need for ECMO. One study was not included in the meta-analysis for o/e-TLV because the results were expressed as medians 58 , yet its conclusions were consistent with the statistical pooling of the other studies.
Similarly, a meta-analysis of 10 studies reporting on the presence of liver herniation demonstrated that liver herniation significantly predicted the need for ECMO (RR, 3.04 (95% CI, 2.23-4.14)). There was no heterogeneity (I 2 = 0%, P = 0.596) nor evidence of publication bias among the studies ( Figure S2 ). The results of one study could not be pooled in the analysis, because it reported only odds ratios 56 . In that series, liver herniation was not associated with a need for ECMO.
The association between the need for ECMO and LHR < 1 (RR, 1.67 (95% CI, 1.26-2.23)) or liver herniation (RR, 3.01 (95% CI, 2.21-4.11)) remained significant even when one study including only patients who underwent fetal tracheal occlusion was removed from the analysis 64 . 
DISCUSSION
Obtaining evidence on antenatal predictors of outcome in cases with rare congenital anomalies is a major challenge, first because of the low incidence of these conditions and second, because of a lack of standardization for testing and of adequately sized prospective studies. Additionally, there is a lack of standardized time points for measurement, inconsistencies in perinatal management protocols, prenatal interventions and effects of gestational age at delivery and postnatal events on the outcomes studied. Prenatal prediction studies of CDH have been significantly boosted by the introduction of fetal therapy, and when the condition is isolated, lung size and liver position can be used, to a certain extent, to predict lethal pulmonary hypoplasia 67, 68 . To further improve prediction, we looked at other determinants of outcome; PPH is commonly associated with poor long-term outcome 14, 69 . The need and relevance of assessing the risk for PPH prior to birth are acknowledged by experts 13 . Alongside PPH, severe ventilatory insufficiency may also lead to the need for ECMO 29 , which may on its own Heling (2005) 35 (n = 17) (a) Garcia (2013) 63 (n = 106) 64 Jani (2009) 37 (n = 100) (c) 66 (n = 97) Garcia (2013) 63 be an independent predictor of outcome owing to the complications associated with this therapy 14 . Overall, we identified more than 15 claimed predictors for each of these adverse outcomes. Most were direct or indirect measurements of lung size 21, 26, 32, 33, 35, 37, 40, 41, 43, 45, 46, [48] [49] [50] [51] [53] [54] [55] [56] [57] [58] [60] [61] [62] [63] [64] [65] [66] , by either MRI or US. Other indicators concern herniation of abdominal organs into the thorax, among which the most commonly evaluated was liver herniation 36, 40, [43] [44] [45] 47, 50, 51, 56, 57, 61, 64, 66, 70 , either categorized as absent or present, or quantified. For the prediction of PPH, attempts to assess directly pulmonary vasculature include measurements of the pulmonary arterial diameters 26, 39, 40 , studies of flow in the pulmonary arteries 33, 34, 71 , with or without hyperoxygenation, or more complex three-dimensional power Doppler techniques 38, 40, 41 . These indicators, however, were assessed in only a single study 72 or they provided inconsistent findings. For most of these variables, a normative study on healthy fetuses, enabling a more comprehensive interpretation of the results, is lacking. Ultimately, the vast majority of the studies reporting on PPH presented an uncertain or high risk of bias, mainly owing to an unspecified or broad range of gestational age at testing. We were able to perform a meta-analysis only of studies reporting on lung size and liver herniation. Surprisingly, the results of the two target outcomes were conflicting. We found a three-fold increase in the risk for ECMO when the liver was herniated and a 1.7-fold increase when LHR was < 1.0. However, smaller lung size or liver herniation was not associated with an increased risk of PPH. There are many possible explanations for this. First, the number of studies included in the meta-analysis for PPH was lower than that for ECMO, thus reducing the statistical power to detect a difference. Second, we observed significant heterogeneity among studies reporting on PPH, perhaps owing to a more heterogeneous study population; unlike studies on ECMO, most studies (> 80%) concerning PPH included left-and right-sided CDH cases, with 20% including both fetuses managed expectantly and those that had invasive fetal surgery. Finally, a lack of consistency in the timing of the postnatal assessment of PPH further complicated the analysis; only two studies reported the exact timing of echocardiographic evaluation of PPH. Standardization of the time point of assessment for PPH is important, as its incidence decreases during the first weeks after delivery 73 . Later evaluation may exclude neonates with severe PPH that died in the early postnatal period, introducing ascertainment bias. Similarly, some studies reported on only PPH refractory to first-line therapy (iNO), thus cases that resolved after initial therapy were not included, hence the incidence of PPH was underestimated. Finally, resorting to ECMO may be influenced by other aspects of postnatal management, including ventilation modality or access to alternative treatments for PPH, and ECMO can be administered for respiratory failure other than PPH 74 . The strengths of our study include a sensitive search strategy and rigorous study selection and quality assessment in line with the most recent guidelines for the conduct and reporting of systematic reviews. This is the first study to investigate the predictive value of prenatally relevant morbidity indicators for PPH. Nevertheless, our review also has limitations. Although a substantial number of studies were included, many predictors were only assessed by a single research group, thereby limiting our ability to pool data and limiting the statistical power to detect heterogeneity and publication bias across studies. Furthermore, adjustments for potential confounding factors, such as side of the hernia and intrauterine management, were not consistent across studies. To increase the homogeneity among study populations, we performed a subanalysis of studies including only patients managed expectantly in utero, confirming the results obtained previously. However, this further reduced the number of pooled studies, especially in the analysis of tests for PPH. Finally, the reviewed literature spans a 30-year time period that has seen dramatic changes in perinatal practice influencing directly the outcome parameters.
Despite these limitations, this systematic review condenses the existing knowledge on the prenatal prediction of PPH and the need for ECMO, while concurrently providing direction for future research. It definitively demonstrates the need for larger (collaborative) studies to adjust for bias. It also highlights the need for standardized prenatal assessment methods, at standardized time points in gestation alongside standardization of postnatal criteria and time points of assessment of PPH.
In conclusion, our meta-analysis demonstrates that ECMO can be predicted reliably by liver position and lung size, but a reliable predictor of PPH is still to be determined.
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Figure S1
Summary of methodological quality of included studies on 11 items of QUADAS checklist for each study reporting on occurrence of persistent pulmonary hypertension (a) and need for extracorporeal membrane oxygenation (ECMO; b). Studies reporting on both outcomes are included in both tables. RS, reference standard.
Figure S2
Funnel plot of publication bias in studies reporting on association between need for extracorporeal membrane oxygenation and presence of liver herniation in fetuses with congenital diaphragmatic hernia. Table S1 Characteristics of studies reporting on prenatal prediction of occurrence of persistent pulmonary hypertension (PPH), need for extracorporeal membrane oxygenation (ECMO) or both, in fetuses with congenital diaphragmatic hernia (CDH) El tamaño pulmonar y la hernia hepática predicen la necesidad de oxigenación por membrana extracorpórea, pero no la hipertensión pulmonar, en casos de hernia diafragmática congénita aislada: revisión sistemática y metaanálisis
RESUMEN
Objetivos Identificar parámetros prenatales indicativos de hipertensión pulmonar persistente (HPP) y la necesidad de oxigenación por membrana extracorpórea (OMEC) en fetos con hernia diafragmática congénita (HDC).
Métodos Se realizó una revisión sistemática de la literatura sobre pruebas de diagnóstico prenatal en fetos con HDC aislada. Los resultados primarios evaluados fueron la HPP en los primeros 28 días de edad y la necesidad de OMEC. La calidad de los estudios se evaluó con la herramienta QUADAS-2. Se realizó un metaanálisis cuando al menos tres estudios habían informado sobre la misma prueba. El análisis de sensibilidad se realizó de acuerdo con la atención prenatal de la HDC (oclusión traqueal frente a la conducta expectante de la gestante).
Resultados Un total de 38 estudios cumplieron los criterios de inclusión. De ellos, 15 reportaron solamente la incidencia de HPP, 19 sobre la necesidad de sólo OMEC y 4 reportaron ambos resultados. La calidad general de los estudios fue moderada: la mayoría de los estudios fueron retrospectivos (61%) y series en un solo centro (92%). Un estudio incluyó sólo fetos sometidos a oclusión traqueal, 22 sólo incluyeron fetos con conducta expectante en elútero y 15 incluyeron ambas poblaciones. No se pudieron identificar parámetros prenatales indicativos de HPP. La necesidad de OMEC fue predicha mediante parámetros indicativos del tamaño del pulmón: la razón pulmón cabeza (LHR, por sus siglas en inglés) (riesgo relativo (RR) para LHR < 1, 1,65 (IC 95%, 1,27-2,14)) y LHR observada/esperada (diferencia de medias estandarizadas (DME)) (IC 95%, −0,98 a −0,42)) medida mediante ecografía y la DME del volumen pulmonar total observado/esperado, −1,00 (IC 95%, −1,52 a −0,48)) medida mediante resonancia magnética. La hernia hepática se asoció también con un mayor riesgo de la necesidad de OMEC (RR 3,04 (IC 95%, 2,23-4,14)). Estos resultados fueron confirmados por un análisis de sensibilidad de los estudios que incluyeron sólo casos manejados con conducta expectante. Los datos sobre la evaluación vascular para la predicción de la HPP no se pudieron agrupar, ya que la mayoría de los parámetros se habían evaluado a partir de una sola serie, o de diferentes series realizadas por el mismo investigador principal.
Conclusiones Aunque el tamaño del pulmón y la hernia hepática predicen la necesidad de OMEC en los fetos con HDC, aún se carece de un parámetro para predecir la HPP. Por lo tanto, es necesaria la realización de más estudios destinados a diagnosticar el retraso del desarrollo vascular en elútero.
